These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3535009)

  • 1. Colicinogeny in chronic inflammatory bowel disease.
    Bures J; Horák V; Buresová E; Fixa B; Komárková O; Hartmann M
    Scand J Gastroenterol; 1986 Sep; 21(7):819-23. PubMed ID: 3535009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Colicinogeny in nonspecific intestinal inflammations and colorectal cancer].
    Bures J; Horák V; Tichý M; Pidrman V; Jandík P; Fixa B; Komárková O
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1991; 34(3):349-403. PubMed ID: 1819866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Colicinogens in nonspecific intestinal inflammations. II. Test of leukocyte migration inhibition with colicins].
    Bures J; Horák V; Buresová E; Fixa B; Komárková O
    Cesk Gastroenterol Vyz; 1983 Apr; 37(3):186-90. PubMed ID: 6347404
    [No Abstract]   [Full Text] [Related]  

  • 4. Cellular hypersensitivity to components of intestinal mucosa in ulcerative colitis and Crohn's disease.
    Bendixen G
    Gut; 1969 Aug; 10(8):631-6. PubMed ID: 5810973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte migration test in Crohn's disease, ulcerative colitis, and ankylosing spondylitis using Crohn's colon homogenate, mitochondrial, and microsomal fractions.
    Williams MJ; Richens ER; Gough KR; Ancill RJ
    Am J Dig Dis; 1975 May; 20(5):425-9. PubMed ID: 1130367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Colicinogens in nonspecific intestinal inflammation. I. Colicinotypes in patients with ulcerous colitis, Crohn's disease and in healthy individuals].
    Bures J; Horák V; Buresová E; Fixa B; Komárková O
    Cesk Gastroenterol Vyz; 1983 Mar; 37(2):81-6. PubMed ID: 6342822
    [No Abstract]   [Full Text] [Related]  

  • 7. Escherichia coli isolates from patients with inflammatory bowel disease: ExPEC virulence- and colicin-determinants are more frequent compared to healthy controls.
    Micenková L; Frankovičová L; Jaborníková I; Bosák J; Dítě P; Šmarda J; Vrba M; Ševčíková A; Kmeťová M; Šmajs D
    Int J Med Microbiol; 2018 Jul; 308(5):498-504. PubMed ID: 29735381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and humoral response to Kunin antigen (CA) in ulcerative colitis and Crohn's disease.
    Bartnik W; Kałuzewski S
    Arch Immunol Ther Exp (Warsz); 1979; 27(4):531-8. PubMed ID: 518259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease.
    Giaffer MH; Holdsworth CD; Duerden BI
    Gut; 1992 May; 33(5):646-50. PubMed ID: 1612481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Escherichia coli Nissle 1917 producing recombinant colicins for treatment of IBD patients.
    Kotłowski R
    Med Hypotheses; 2016 Aug; 93():8-10. PubMed ID: 27372848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of atopy is unrelated to presence of inflammatory bowel disease.
    Troncone R; Merrett TG; Ferguson A
    Clin Allergy; 1988 Mar; 18(2):111-7. PubMed ID: 3365856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia trachomatis and inflammatory bowel disease--a coincidence?
    Orda R; Samra Z; Levy Y; Shperber Y; Scapa E
    J R Soc Med; 1990 Jan; 83(1):15-7. PubMed ID: 2304046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Virus, Crohn's disease, ulcerative colitis and non-specific enterocolitis].
    Poynard T; Girard-Pipau F; Pérol Y
    Gastroenterol Clin Biol; 1981 May; 5(5):537-53. PubMed ID: 7018982
    [No Abstract]   [Full Text] [Related]  

  • 14. Transmissible agents in inflammatory bowel disease: 1980.
    Beeken WL
    Med Clin North Am; 1980 Nov; 64(6):1021-35. PubMed ID: 7007757
    [No Abstract]   [Full Text] [Related]  

  • 15. [Presence of intracellular Escherichia coli in patients with inflammatory bowel disease].
    De La Fuente M; Chahuán I; Gutiérrez R; Díaz-Jiménez D; Olivares M; Vidal R; Simian D; Figueroa C; Quera R; Hermoso MA
    Rev Med Chil; 2017 Sep; 145(9):1129-1136. PubMed ID: 29424399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of infection in the aetiology of inflammatory bowel disease.
    Hansen R; Thomson JM; El-Omar EM; Hold GL
    J Gastroenterol; 2010 Mar; 45(3):266-76. PubMed ID: 20076977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atopy in inflammatory bowel disease.
    Mee AS; Brown D; Jewell DP
    Scand J Gastroenterol; 1979; 14(6):743-6. PubMed ID: 531506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory bowel disease: progress and current concepts of etiopathogenesis.
    Scaldaferri F; Fiocchi C
    J Dig Dis; 2007 Nov; 8(4):171-8. PubMed ID: 17970872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunology of chronic ulcerative colitis and Crohn's disease.
    Shorter RG; Tomasi TB; Huizenga KA; Spencer RJ; Stobo JD
    Ann N Y Acad Sci; 1976; 278():586-91. PubMed ID: 786126
    [No Abstract]   [Full Text] [Related]  

  • 20. In-vitro inhibition of leucocyte migration in Crohn's disease by a sarcoid spleen suspension.
    Willoughby JM; Mitchell DN
    Br Med J; 1971 Jul; 3(5767):155-7. PubMed ID: 5557864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.